Genome Editing
Support and Educational Content

CRISPR guide RNA format affects genome editing outcomes

Not all CRISPR-Cas9 systems are equal

CRISPR-Cas9 genome editing uses the bacteria-derived Cas9 endonuclease to generate double-stranded breaks in DNA. The cleaved DNA is then repaired by non-homologous end joining (NHEJ) or homologous recombination, resulting in a modified sequence. When selecting CRISPR-Cas9 reagents, there are several options with different advantages and disadvantages, depending on the experiments you will perform. One of the potential disadvantages you should consider when selecting a CRISPR method, especially for gene disruption by NHEJ, is that the CRISPR guide RNA format can change the outcomes within the targeted site(s).

Benefits of short RNAs for guiding Cas9

Guiding the Cas9 endonuclease to genomic DNA targets is relatively simple compared with other genome editing tools, such as TALEN or zinc-finger nuclease approaches. Unlike with those methods, the Cas9 enzyme does not need to be engineered for every unique sequence. Instead, Cas9 relies on association with short CRISPR RNA (crRNA) and transactivating CRISPR RNA (tracrRNA) molecules to recognize target sequences. Target sites must also contain a protospacer adjacent motif (PAM) immediately downstream of the crRNA recognition sequence. This PAM sequence is a short NGG motif and it must be on the non-targeting strand (Figure 1). These short RNAs are easy to synthesize using standard chemical and molecular techniques, and this simplicity is the main reason why CRISPR-Cas9 genome editing has quickly become the dominant gene editing method.

As shown in Figure 1, for each specific target site, Cas9 requires a separate crRNA and tracrRNA that are annealed to each other through homology domains to form a crRNA:tracrRNA guide complex. Alternatively, the crRNA and tracrRNA can be effectively combined with a short linker loop into a chimeric single-guide RNA (sgRNA), which is widely used by many labs [1, 2].

CRISPR Guide Types (panel A and B)

Figure 1. Types of CRISPR-Cas9 guide RNA. (A) Wild-type S. pyogenes CRISPR systems use a separate crRNA and tracrRNA. The crRNA and tracrRNA sequences used in the Alt-R™ CRISPR-Cas9 System mimic those found in S. pyogenes, and have been length-optimized for performance and easy manufacturing. (B) Another common approach is to combine the crRNA and tracrRNA into a fusion sgRNA by adding a short linker sequence between the components. For both guide types, the cleavage site is specified by the protospacer element within the crRNA (thick green bar).The crRNA and tracrRNA form a complex with the Cas9 endonuclease to guide Cas9 and activate the endonuclease for cleavage of genomic DNA. In addition to the protospacer element, all targets for S. pyogenes Cas9 require a short NGG protospacer adjacent motif (PAM) immediately downstream of the target sequence on the opposite strand. Cleavage will not occur at sites lacking this PAM sequence. Double-stranded cleavage typically occurs 3 bases from the PAM site in the target sequence.

Among the methods for producing CRISPR guide RNA, DNA constructs that express the RNA are convenient and easy to work with. However, when double-stranded DNA is used for NHEJ gene disruption, it can leave a molecular footprint at the genomic target site.

We used Sanger sequencing of PCR amplicons to evaluate the editing efficiency of CRISPR-Cas9 transfections, and cataloged the types of mutations generated by different Cas9 trigger types. The pie charts in Figure 2 show that when sgRNAs are introduced as DNA expression constructs—as either plasmid (Figure 2C, 2D) or gBlocks® Gene Fragment constructs (Figure 2B)—we observed more multiple-base insertions. Furthermore, these insertions regularly included a footprint in the form of several hundred inserted nucleotides that corresponded to large sections of the expression cassette. Scientists using expression cassette sgRNAs need to consider that the DNA template can be integrated into the double stranded break and become part of the genome of their organism.

In contrast, Figure 2A shows that single-stranded RNA oligonucleotides produce fewer multiple-base insertions. Furthermore, these RNAs cannot be incorporated into genomic DNA. For most applications, avoiding the incorporation of the artificial CRISPR constructs is a preferred outcome, which is one reason why we use RNA oligos to manufacture the CRISPR RNAs for our Alt-R™ CRISPR-Cas9 System.

Pie charts ungrouped

Figure 2. Type and proportion of mutations observed differs with CRISPR guide RNA formats. Four different CRISPR guide RNA formats targeting the HPRT 38285-AS site were transfected into HEK293-Cas9 cells that stably express S. pyogenes Cas9, or wild-type HEK293 cells (used only for delivery of the large plasmid). Genomic DNA was isolated and editing measured by PCR amplification of target sites, followed by cleavage with T7EI mismatch endonuclease (New England Biolabs), and analysis using the Fragment Analyzer™ (Advanced Analytical). Sanger sequencing was performed for cloned amplicons (“n”) to identify the type of sequence mutation produced by CRISPR editing. Mutation percentages based on T7EI assays are shown for comparison.

Detection of mutations with mismatch endonucleases

Just as there are many ways to edit the genome, there are many ways to assess the editing results. Mismatch endonucleases such as T7EI and Surveyor® endonuclease are cost effective and easily adapted for high throughput screening of CRISPR genome editing. Mismatch endonuclease assays for either T7EI or Surveyor® endonuclease are very similar. Both enzymes require PCR amplification of the edited DNA, followed by formation of heteroduplexes between mutant and wild-type DNA. These mismatched products are then incubated with the endonuclease, which recognizes and cleaves only the mismatched DNA, and results can be visualized by electrophoresis. However, in order to use this approach, it is important to understand what the assay limitations are and how to interpret your results.

Compared to sequencing, enzymatic mismatch analysis methods reflect a lower than actual editing efficiency. This is because the mismatch cleavage enzymes do not efficiently cleave every type of mismatch and, as we have discussed, CRISPR genome editing produces a mix of insertions and deletions. Generally, T7EI cleaves deletions more effectively, and it is not as sensitive to PCR buffer conditions as Surveyor endonuclease. However, T7EI does not detect single-base changes as well as Surveyor endonuclease [3].

IDT uses T7EI in our screening and the Fragment Analyzer capillary electrophoresis instrument (Advanced Analytical) to quantify our results. Figure 2 shows that our T7EI assays resolved ~50% of the mutation frequency that was seen by Sanger sequencing. Analysis of the sequencing data shows that single base changes are common in NHEJ repairs, and those are typically missed by T7EI. Based on these results, when we analyze our own T7EI data, we consider editing event values of ≥20% to be good performance, and we reasonably expect that Sanger sequencing data would show 40–50% actual editing events for the same samples. Our protocol for CRISPR mutation detection using T7EI nuclease can be downloaded at www.idtdna.com/CRISPR.

     

    Research optimized Alt-R® CRISPR-Cas9 System

    The Alt-R CRISPR-Cas9 System is the product of extensive research, including testing of common methods for generating the crRNA and tracrRNA complex. These studies led us to use shortened crRNA and tracrRNA components of 36 and 67 nt, respectively, in the  Alt-R CRISPR-Cas9 System, compared to the natural S. pyogenes 42 nt crRNA and 89 nt tracrRNA. This format has the advantage of producing edits without incorporation of artificial CRISPR constructs, as described in this article, and the Alt-R CRISPR-Cas9 System outperforms other CRISPR guide technologies in overall performance. Finally, affordable crRNAs and the ability to purchase bulk quantities of highly purified tracrRNA also make the system ideal for making crRNA libraries and/or for high-throughput studies. See more data and download protocols at www.idtdna.com/CRISPR.

    References 

    1. Jinek M, Chylinski K, et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096):816–821.
    2. Makarova KS, Grishin NV, et al. (2006) A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biology direct, 1:7
    3. Vouillot L, Thélie A, et al. (2015) Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases G3: Genes|Genomes|Genetics, 5(3):407–415.

     

    Product focus—genome editing with Alt-R® CRISPR Reagents

    Alt-R CRISPR-Cas9 System

    The Alt-R CRISPR-Cas9 System includes all the reagents needed for successful genome editing. Based on the natural S. pyogenes CRISPR-Cas9 system, the Alt-R CRISPR-Cas9 System offers numerous advantages over alternative methods:

    • Higher on-target potency than other CRISPR systems
    • Precision control with delivery of Cas9 ribonucleoprotein (RNP)
    • Efficient delivery of the RNP with lipofection or electroporation
    • No toxicity or innate immune response activation, in contrast to in vitro transcribed Cas9 mRNA and sgRNAs

    Learn more about the Alt-R CRISPR-Cas9 System.


    Alt-R CRISPR-Cpf1 System

    The Alt-R CRISPR-Cpf1 System allows for new CRISPR target sites that are not available with the CRISPR-Cas9 System, and produces a staggered cut with a 5′ overhang. These reagents:

    • Enable genome editing in organisms with AT-rich genomes
    • Allow interrogation of additional genomic regions compared to Cas9
    • Require simply complexing the crRNA with the Cpf1 protein—no tracrRNA needed
    • Permit efficient delivery of the RNP into cells by electroporation

    Learn more about the Alt-R CRISPR-Cpf1 System.


    CRISPR support tools

    Additional CRISPR reagents extend the ease-of-use and performance of the Alt-R system through options for fluorescent visualization, enhanced nuclease transfection, and genome editing detection.

    Find out more about IDT’s entire line of CRISPR products.

    Related reading

    Improve your genome editing with the Alt-R® S.p. Cas9 Nuclease 3NLS and modified crRNAsProduct Spotlight: Methods for CRISPR-Cas9 genome editing are diverse, but not all of them perform equally well. Learn how the Alt-R S.p. Cas9 Nuclease 3NLS, when used in combination the optimized Alt-R CRISPR crRNA and tracrRNA, provides a highly effective editing solution that is also easy to use. 

    Getting started with Alt-R® CRISPR-Cas9 genome editing—Learn about the components of the Alt-R CRISPR-Cas9 System, get information on designing Alt-R CRISPR crRNA oligos, and review the genome editing protocol from the user guide.

    Consistent, high performance genome editing—Learn how to improve the performance of your CRISPR-Cas9 genome editing application. The Alt-R® CRISPR-Cas9 System offers potent on-target editing, easy implementation, and reduced cellular toxicity.

    CRISPR genome editing: 5 considerations for target site selectionRead how your genome editing experiments can be improved with 5 quick tips for target selection and with reagents from the Alt-R® CRISPR-Cas9 System.

    Review other DECODED Online newsletter articles on genome editing applications.

     

    You can also browse our DECODED Online newsletter for additional application reviews, lab tips, and citation summaries to facilitate your research.

    Author: Hans Packer, PhD, is a scientific writer at IDT.

    © 2016 Integrated DNA Technologies. All rights reserved. Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners. For specific trademark and licensing information, see www.idtdna.com/trademarks.


    CRISPR-Cas9 Genome Editing

    With Alt-R CRISPR-Cas9 System get the core components for improved on-target editing performance, while experiencing lower toxicity, and no innate cellular response.

    Increase your editing efficiency ≫


    Related Content

    Product page:

    Alt-R CRISPR-Cas9 System

    Webinar:

    New RNA tools for optimized CRISPR/Cas9 genome editing

    Learn how research conducted at IDT led to the development of a potent new set of CRISPR-Cas9 genome editing tools.

    Poster:

    Quantitative Measurement of CRISPR/Cas9 Gene Editing at the Level of Genomic DNA for sgRNA Site Selection Algorithm Development

    User guide:

    Alt-R CRISPR-Cas9 System User Guide